Hamps Bio IPO, a fixed-price issue set to list on the BSE SME platform on tomorrow, (December 20). Ahead of its listing, the SME issue has garnered significant investor attention, with its grey market premium (GMP).
GMP
As per the latest trend, the GMP of Hamps Bio IPO was trading at Rs 55, with an estimated listing of Rs 106 per share or marking a 107.84 per cent gain, ahead of the listing.
The GMP of Rs 106 per share in the unofficial market reflects strong sentiment around the IPO.
Subscription Numbers
The SME IPO, opened for bidding from December 13 to December 17 and received an overwhelming participation. By the end of the final day, the issue was subscribed by 1,057 times.
Retail investors category of the issue saw a subscription rate of 596.06 times, while non-institutional investors subscribed 116.16 times.
Also Read: International Gemological Institute IPO 2024 live updates: Check IPO allotment status, GMP, subscription status, and other details
The issue is structured to allocate 50 per cent of the shares to qualified institutional buyers (QIBs), 35 per cent to retail investors, and 15 per cent to non-institutional investors.
Hamps Bio’s IPO is entirely a fresh issue, offering 12.2 lakh shares to raise Rs 6.22 crore.
The price is fixed at Rs 51 per share, with a minimum application size of 2,000 shares. This translates to a minimum investment of Rs 1,02,000 for retail investors. High-net-worth individuals (HNIs) need to invest in at least two lots, amounting to a sum of Rs 2,04,000.
Purpose of the IPO
The proceeds from the issue will be utilised to enhance specific growth initiatives, including purchasing machinery for the FMCG division, enhancing brand visibility, and general corporate expenses.
» Read More
